Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ligand Pharm (LGND)
Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,021,515
  • Shares Outstanding, K 17,355
  • Annual Sales, $ 196,250 K
  • Annual Income, $ -33,360 K
  • 60-Month Beta 1.02
  • Price/Sales 5.22
  • Price/Cash Flow 11.66
  • Price/Book 1.54
Trade LGND with:

Options Overview Details

View History
  • Implied Volatility 29.67% ( +1.45%)
  • Historical Volatility 25.96%
  • IV Percentile 4%
  • IV Rank 8.36%
  • IV High 68.87% on 11/07/22
  • IV Low 26.09% on 09/13/23
  • Put/Call Vol Ratio 0.50
  • Today's Volume 3
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 1,520
  • Open Int (30-Day) 1,466

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate 0.31
  • Number of Estimates 2
  • High Estimate 0.36
  • Low Estimate 0.25
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +255.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.94 +5.09%
on 09/25/23
67.48 -9.77%
on 09/01/23
-4.50 (-6.88%)
since 08/25/23
3-Month
57.94 +5.09%
on 09/25/23
73.85 -17.55%
on 06/30/23
-11.37 (-15.73%)
since 06/26/23
52-Week
57.77 +5.40%
on 11/02/22
97.65 -37.64%
on 10/06/22
-16.24 (-21.06%)
since 09/26/22

Most Recent Stories

More News
Ligand: Q2 Earnings Snapshot

Ligand: Q2 Earnings Snapshot

LGND : 60.93 (+3.52%)
Time to Capitalize on These 3 Hot Biotech Stocks

The biotech industry is well-positioned for growth thanks to rising demand for quality healthcare, the prevalence of chronic diseases, and the government’s push to boost domestic biotech production and...

ACOR : 15.50 (-2.88%)
CORT : 32.54 (+0.68%)
LGND : 60.93 (+3.52%)
XBI : 73.70 (+2.53%)
Exelixis (EXEL) Q1 Earnings Miss, Revenues Increase Y/Y

Exelixis (EXEL) misses first quarter 2023 earnings and sales estimates, but product sales increase year over year.

BMY : 58.74 (-0.71%)
EXEL : 21.86 (+0.14%)
LGND : 60.93 (+3.52%)
SPRO : 1.2100 (+0.83%)
bluebird (BLUE) Posts Q1 Earnings, Focuses on Zynteglo, Skysona

bluebird bio (BLUE) delivers earnings of 21 cents per share in the first quarter, due to a one-time gain. Revenues increase year over year.

LGND : 60.93 (+3.52%)
PCRX : 33.10 (+0.95%)
BLUE : 3.12 (+2.97%)
SPRO : 1.2100 (+0.83%)
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View

Novavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However, shares rise on the back of encouraging 2023 guidance and cost-reduction initiatives.

NVAX : 7.11 (-2.74%)
LGND : 60.93 (+3.52%)
ALLO : 3.41 (-2.85%)
ATHA : 1.9800 (+1.01%)
Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus

Denali (DNLI) delivers a wider Q1 loss while collaboration revenues surpass estimates.

SNY : 54.29 (-0.11%)
BIIB : 257.54 (+0.99%)
LGND : 60.93 (+3.52%)
DNLI : 21.41 (-2.64%)
Viatris (VTRS) Q1 Earnings Beat, Revenues Miss Estimates

Viatris (VTRS) beats on Q1 earnings but misses sales. The company is now looking to reshape its business after selling its biosimilars portfolio.

LGND : 60.93 (+3.52%)
PCRX : 33.10 (+0.95%)
SPRO : 1.2100 (+0.83%)
VTRS : 9.73 (+0.10%)
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings

Ligand Pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management raises 2023 financial outlook.

LGND : 60.93 (+3.52%)
VKTX : 12.03 (+3.08%)
TVTX : 8.51 (+5.71%)
OABI : 5.28 (+6.02%)
Wall Street Analysts Believe Ligand (LGND) Could Rally 38.66%: Here's is How to Trade

The mean of analysts' price targets for Ligand (LGND) points to a 38.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in...

LGND : 60.93 (+3.52%)
Bausch Health's (BHC) Q1 Earnings & Sales Miss, Shares Down

Bausch (BHC) declines as it misses on earnings and sales in the first quarter.

LGND : 60.93 (+3.52%)
FATE : 2.06 (-0.96%)
SPRO : 1.2100 (+0.83%)
BHC : 8.20 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated...

See More

Key Turning Points

3rd Resistance Point 61.20
2nd Resistance Point 60.36
1st Resistance Point 59.61
Last Price 60.93
1st Support Level 58.03
2nd Support Level 57.19
3rd Support Level 56.44

See More

52-Week High 97.65
Fibonacci 61.8% 82.42
Fibonacci 50% 77.71
Fibonacci 38.2% 73.00
Last Price 60.93
52-Week Low 57.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar